MDT

94.96

-0.45%↓

VEEV

289.77

-0.25%↓

A

141

+0.33%↑

HQY

91.04

-1.54%↓

TLRY

1.51

-8.48%↓

MDT

94.96

-0.45%↓

VEEV

289.77

-0.25%↓

A

141

+0.33%↑

HQY

91.04

-1.54%↓

TLRY

1.51

-8.48%↓

MDT

94.96

-0.45%↓

VEEV

289.77

-0.25%↓

A

141

+0.33%↑

HQY

91.04

-1.54%↓

TLRY

1.51

-8.48%↓

MDT

94.96

-0.45%↓

VEEV

289.77

-0.25%↓

A

141

+0.33%↑

HQY

91.04

-1.54%↓

TLRY

1.51

-8.48%↓

MDT

94.96

-0.45%↓

VEEV

289.77

-0.25%↓

A

141

+0.33%↑

HQY

91.04

-1.54%↓

TLRY

1.51

-8.48%↓

Search

10X Genomics Inc (Class A)

Atvērts

SektorsVeselības aprūpe

12.24

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

12.12

Max

12.63

Galvenie mērījumi

By Trading Economics

Ienākumi

69M

35M

Pārdošana

18M

173M

EPS

0.28

Peļņas marža

19.975

Darbinieki

1,306

EBITDA

86M

47M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+23.21% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 6. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-240M

1.4B

Iepriekšējā atvēršanas cena

12.24

Iepriekšējā slēgšanas cena

12.24

Ziņu noskaņojums

By Acuity

17%

83%

25 / 371 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bullish Evidence

10X Genomics Inc (Class A) Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 16. okt. 21:10 UTC

Galvenie tirgus virzītāji

Kezar Life Sciences Shares Surge After Break with FDA, Restructuring Plan

2025. g. 16. okt. 19:03 UTC

Iegādes, apvienošanās, pārņemšana

Canada Signals Limited Concern Over U.S. Government Stakes in Canadian Miners -- 2nd Update

2025. g. 16. okt. 17:58 UTC

Iegādes, apvienošanās, pārņemšana

Canada Signals Limited Concern Over U.S. Government Stakes in Canadian Miners -- Update

2025. g. 16. okt. 17:12 UTC

Peļņas

Ray-Ban Maker EssilorLuxottica's Revenue Surges to Quarterly Record -- Update

2025. g. 16. okt. 17:12 UTC

Iegādes, apvienošanās, pārņemšana

Canada Signals Limited Concern Over US Government Stakes in Canadian Miners

2025. g. 16. okt. 16:59 UTC

Iegādes, apvienošanās, pārņemšana

Airbus's Takeover of Spirit AeroSystems Plants Gets French Antitrust Clearance

2025. g. 16. okt. 23:44 UTC

Tirgus saruna

Gold Climbs Amid Safe-Haven Demand -- Market Talk

2025. g. 16. okt. 23:42 UTC

Tirgus saruna

Nikkei May Fall, Tracking Wall Street's Declines -- Market Talk

2025. g. 16. okt. 23:42 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 16. okt. 22:15 UTC

Peļņas

China Tower: Results Supported by Higher Contributions From Energy, Smart Tower Business >0788.HK

2025. g. 16. okt. 22:15 UTC

Peļņas

China Tower 9-Mos Rev CNY74.32B Vs. CNY72.45B >0788.HK

2025. g. 16. okt. 22:15 UTC

Peļņas

China Tower 9-Mos Net CNY8.71B Vs. Net CNY8.15B >0788.HK

2025. g. 16. okt. 22:02 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 16. okt. 22:02 UTC

Tirgus saruna

Santos Drifts Into 'Oversold Territory' -- Market Talk

2025. g. 16. okt. 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 16. okt. 20:50 UTC

Tirgus saruna
Peļņas

Health Care Roundup: Market Talk

2025. g. 16. okt. 20:23 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 16. okt. 20:23 UTC

Tirgus saruna

Recession Risks to Push Canada Toward October Rate Cut -- Market Talk

2025. g. 16. okt. 20:20 UTC

Peļņas

These Stocks Moved the Most Today: TSMC, Salesforce, HPE, F5, United Airlines, Travelers, J.B. Hunt, Praxis Precision, and More -- Barrons.com

2025. g. 16. okt. 20:08 UTC

Iegādes, apvienošanās, pārņemšana

Jack in the Box to Sell Del Taco With Big Markdown. The Stock Plunged. -- Barrons.com

2025. g. 16. okt. 19:37 UTC

Iegādes, apvienošanās, pārņemšana

Crypto Industry Dives Deeper Into Prediction Markets as Kraken Buys Exchange -- Barrons.com

2025. g. 16. okt. 19:26 UTC

Peļņas

Oracle Weighs In on Cloud Margins. The Stock Is Rising. -- Barrons.com

2025. g. 16. okt. 19:24 UTC

Tirgus saruna

U.S. Natural Gas Falls on Mild Weather, Ample Storage -- Market Talk

2025. g. 16. okt. 19:23 UTC

Tirgus saruna

Oil Falls As Oversupply Concerns Outweigh India News -- Market Talk

2025. g. 16. okt. 19:23 UTC

Peļņas

Oracle Weighs In on Cloud Margins. The Stock Is Rising. -- Barrons.com

2025. g. 16. okt. 18:35 UTC

Tirgus saruna
Peļņas

Charles Schwab Logs Another Quarter of Record Revenues, Earnings -- Market Talk

2025. g. 16. okt. 18:31 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 16. okt. 18:31 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 16. okt. 18:31 UTC

Tirgus saruna

Charles Schwab Readies Spot Crypto Trading -- Market Talk

2025. g. 16. okt. 16:57 UTC

Tirgus saruna

Oil Futures Lose Ground as EIA Reports Crude Stock Build -- Market Talk

Salīdzinājums

Cenas izmaiņa

10X Genomics Inc (Class A) Prognoze

Cenas mērķis

By TipRanks

23.21% augšup

Prognoze 12 mēnešiem

Vidējais 14.65 USD  23.21%

Augstākais 17 USD

Zemākais 11.5 USD

Pamatojoties uz 14 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi 10X Genomics Inc (Class A) — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

14 ratings

5

Pirkt

9

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

8.32 / 8.63Atbalsts un pretestība

Īstermiņā

Bullish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

No Evidence

Noskaņojums

By Acuity

25 / 371 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Vidējais

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
help-icon Live chat